Our goal with LIFE-L is to show that lifestyle interventions aren’t just for prevention or post-treatment—they can make a real difference during treatment. If we can help patients feel stronger and ...

A genetic variant is likely putting some children suffering with myocarditis — inflammation of the heart muscle — at higher risk of developing heart failure, which can be fatal, according to a study ...

A newly proposed framework outlines how China can develop a localized model of STEM education that aligns with national curriculum while preserving the core principles of STEM. This Chinese-style ...

Images of Nova Cassiopeia 2021 (V1405 Cas) obtained with the CHARA Array between 55 and 67 days after the eruption began. The ...

From August 2025 to September 2025, the employment-to-population ratio decreased from 38.5 to 38.2 percent for people with ...

This November through February, a specialized laser instrument that measures atmospheric gases is hitching a ride on ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...

Treatment with intravenous (IV) iron significantly improved survival and increased hemoglobin levels in patients with iron-deficiency anemia who were hospitalized for an acute bacterial infection, ...

Nearly a third of families with children receiving chemotherapy for acute lymphoblastic leukemia (ALL) – the most common pediatric cancer – develop serious financial difficulties during their child’s ...

Sensitive tests designed to detect very small numbers of remaining leukemia cells after treatment, known as measurable residual disease (MRD), may provide an early and reliable indicator of long-term ...

A new study shows that giving the chemotherapy drug cyclophosphamide after allogeneic hematopoietic cell transplantation, a curative treatment for common types of blood cancer, can make the procedure ...

Compared with white patients, Black patients with acute myeloid leukemia (AML) were on average more than five years younger at diagnosis, more than 30% more likely to die of their disease, and more ...